Reducing the severity of bronchial hyperresponsiveness.
Woolcock
A J
AJ
Department of Medicine, University of Sydney, Australia.
Salome
C M
CM
Keena
V A
VA
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D016084:Bronchoconstriction / Q000187:drug effects; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D006801:Humans; D006990:Hypnosis
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D004205:Cromolyn Sodium